DVIPX
Price
$19.44
Change
-$0.20 (-1.02%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

DVIPX vs VVIAX

Header iconDVIPX vs VVIAX Comparison
Open Charts DVIPX vs VVIAXBanner chart's image
Davenport Value & Income
Price$19.44
Change-$0.20 (-1.02%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DVIPX vs VVIAX Comparison Chart
Loading...
VS
DVIPX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVIPX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. DVIPX (880M). VVIAX pays higher dividends than DVIPX: VVIAX (2.36) vs DVIPX (1.51). DVIPX was incepted earlier than VVIAX: DVIPX (14 years) vs VVIAX (24 years). DVIPX is a more actively managed with annual turnover of: 21.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than DVIPX: VVIAX (3000) vs DVIPX (5000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. DVIPX (15.65). VVIAX return over 5 years is better than : 53.51 vs. DVIPX (27.41).
DVIPXVVIAXDVIPX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years24 years-
Gain YTD10.67913.50679%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets880M183B0%
Annual Yield % from dividends1.512.3664%
Returns for 1 year15.6519.3081%
Returns for 3 years2.6819.6814%
Returns for 5 years27.4153.5151%
Returns for 10 years57.93107.5754%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals